首页> 外文期刊>The Canadian journal of cardiology >VALUE OF TESTING FOR MYOCARDIAL ISCHEMIA IN ISCHEMIC CARDIOMYOPATHY PATIENTS WITH RECURRENT VENTRICULAR ARRHYTHMIA IN A POPULATION BASED COHORT
【24h】

VALUE OF TESTING FOR MYOCARDIAL ISCHEMIA IN ISCHEMIC CARDIOMYOPATHY PATIENTS WITH RECURRENT VENTRICULAR ARRHYTHMIA IN A POPULATION BASED COHORT

机译:缺血性心肌病患者心肌缺血在缺血性心律失常中的群体群体中的缺血患者的价值

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: New Myocardial ischemia is a common trigger for ventricular fibrillation (VF), however, ventricular tachycardia (VT) usually results from an underlying myocardial scar. Current guidelines recommend ischemia testing to be considered in patients with monomorphic VT (MMVT) and to be strongly considered in patients with polymorphic VT (PMVT) or VF. OBJECTIVE: To assess whether testing for myocardial ischemia in ischemic cardiomyopathy (ICM) patients presenting with appropriate implantable cardioverter defibrillator (ICD) therapy would change clinical management.
机译:背景:新的心肌缺血是心室颤动(VF)的常见触发,然而,心室性心动过速(VT)通常由底层心肌瘢痕产生。 目前的指导方针建议在单声族VT(MMVT)患者中考虑缺血测试,并在多晶型VT(PMVT)或VF患者中强烈考虑。 目的:评估是否在缺血性心肌病(ICM)患者中的心肌缺血检测是否患有适当的植入心脏病患者(ICD)治疗将改变临床管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号